Patent · US Expired

Antitumor antibiotic BMY-42428

US5087567A · kind A · utility

2Cited by

5References

6Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Thomas T. Dabrah · Waterford, US
Grace A. Hesler · Branford, US
Sandra J. Hofstead · Middletown, US
Kin S. Lam · Cheshire, US
Jacqueline Mattei · East Haven, US
Daniel R. Schroeder · Higganum, US
Koji Tomita · Setagaya, JP

Key dates

Filing date	Jan 12, 1990
Grant date	Feb 11, 1992
Priority date	—
Expiry date	Jan 12, 2010

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S435/825
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

An antitumor antibiotic designated BMY-42428 is produced by fermentation of Actinomadura madurae ATCC-53806. The BMY-42428 antibiotic exhibits both antimicrobial and antitumor activities.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.